|
Product Details:
|
| CAS No.: | 1165910-22-4 | Purity: | 99% |
|---|---|---|---|
| Shipment: | FedEx, EMS, HKEMS, TNT, DHL, UPS | Policy: | Re-Shipping Policy |
| Molecular Formula:: | C15H14F6N2 | WhatsApp: | +8613545014917 |
| High Light: | weight loss sarms,sarms for muscle growth |
||
LGD-4033 Novel Non-Steroidal SARM Muscle Growth White Ligandrol LGD-4033 For Bulking Up
Product Details
Product name: LGD-4033
Other name: Ligandrol
CAS No.: 1165910-22-4
Assays: 99%
Packing: foil bag
Molecular Formula: C15H14F6N2
Molecular Weight: 336.28
Appearance: White crystalline powder
LGD-4033 is one of the emerging SARMS. It is a nonsteroidal oral SARM that binds with AR and produces steroid-like results minus steroids. This is the closest SARM and can be equated with strong anabolism. As far as the scale can be obtained, LGD-4033 is the strongest of all SARMS.
It is a group of androgen receptor (AR) ligands that are tissue-selective and are used to treat acute and chronic diseases, age-related muscle loss and cancer-related muscular dystrophy. Due to the tissue selective mechanism and its oral administration form, LGD-4033 is expected to produce the healing benefits of testosterone with better safety, acceptability and patient acceptance.
LGD-4033 / Ligandrol introduction
LGD-4033 (Ligandrol) is a selective oral androgen receptor modulator (SARM) that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It is in a class of androgen receptor (AR) ligands that are tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss...
LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.
COA
| TEST | ACCEPTANCE CRITERLA | RESULTS |
| TLC | Positive | |
| Identification | UV spectrum | Positive |
| IR spectrum | Positive | |
| Characteristics | White to yellowish-white crystalline powder | conform |
| Melting point | 32 ~ 37ºC | 33~36ºC |
| Specific optical rotation | +77°~+82° | +79.3° |
| Loss on drying | ≤0.5% | 0.15% |
| Assay | 97 ~ 103% | 99.08% |
| Free heptanoic acid | ≤0.2 % | 0.10% |
| Related substances | ≤2% | Pass |
| Acetone ≤100ppm | Pass | |
| Residual solvents(GC) | Methanol ≤100ppm | Pass |
| Pyridine ≤100ppm | Pass | |
| Particle size | Pass |
Uses
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.
Bulking
LGD has shown the most ability of any SARM to put on size that could be considered a bulk. This will, of course, be dependent upon the diet used. Users that have experienced more than 10lb. increases, and have had a significant increase in calorie intake. The possibility of this type of size is present with LGD use. A recommend dosage for this type of goal would be 5-10 mg day for 8 weeks.
SARMS Product List
Contact Person: Cathy
